Revolutionizing Autoimmune Research: The Role of Caveolin‐1
Immunity, Inflammation and Disease · 2025-08 · 13 (8)
DOI: 10.1002/iid3.70230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 08.08.2025. Verfasst von Yanan Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Hauptthemen laut MEDLINE: Caveolin 1, Autoimmune Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by grants from the National Natural Science Foundation of China (81871292), the Key Research and Development (R&D) Projects of Shanxi Pro….
Abstract (Originalsprache)
Introduction
Caveolins (Cav) include Cav‐1, Cav‐2, and Cav‐3, with Cav‐1 being the most studied due to its prominent role as a major component of plasma membrane caveolae. Cav‐1 is involved in a wide range of cellular functions and plays a key role in regulating signaling pathways related to immune responses and inflammation. Recently, research on Cav‐1 in autoimmune diseases (AIDs) has garnered significant interest.
Methods
This paper provides an overview of the research on Cav‐1's involvement in AIDs, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, anti‐neutrophil cytoplasmic antibody‐associated vasculitis, systemic sclerosis, connective tissue disease‐associated interstitial lung disease, autoimmune disorders of the nervous system, autoimmune uveitis, autoimmune thyroid disease, and autoimmune myocarditis.
Results
Cav‐1 plays a critical role in various AIDs, acting as a key protein in inflammatory and immune cells. It regulates multiple signaling processes by controlling the translocation of signaling molecules and modulating various pathways. Cav‐1 is increasingly recognized as a biomarker in certain AIDs and may become pivotal in treating these diseases in the future.
Conclusion
Cav‐1 is a crucial player in the pathogenesis of many AIDs and has the potential to serve as both a diagnostic marker and a therapeutic target for these diseases. As research into Cav‐1 deepens, it may offer new insights into the diagnosis, treatment, and drug sensitivity of AIDs, emerging as a promising target for future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
- Jiexiu People's Hospital, Jinzhong, China.
ORCID-Profile: Ke Xu
Förderung
- This study was funded by grants from the National Natural Science Foundation of China (81871292), the Key Research and Development (R&D) Projects of Shanxi Pro…
Zitieren
APA
Gao, Y., Mi, L., Deng, Y., Jia, Z., Zhao, M., Hu, Y., Ji, Y., He, X., & Xu, K. (2025). Revolutionizing Autoimmune Research: The Role of Caveolin‐1. Immunity, Inflammation and Disease, 13(8). https://doi.org/10.1002/iid3.70230
Vancouver
Gao Y, Mi L, Deng Y, Jia Z, Zhao M, Hu Y, et al. Revolutionizing Autoimmune Research: The Role of Caveolin‐1. Immunity, Inflammation and Disease. 2025;13(8). doi:10.1002/iid3.70230
BibTeX
@article{Gao2025,
author = {Gao, Yanan and Mi, Liangyu and Deng, Yingren and Jia, Zhaojun and Zhao, Miaomiao and Hu, Yuting and Ji, Yuli and He, Xiaoyao and Xu, Ke},
title = {Revolutionizing Autoimmune Research: The Role of Caveolin‐1},
journal = {Immunity, Inflammation and Disease},
year = {2025},
volume = {13},
number = {8},
doi = {10.1002/iid3.70230}
}
EUVIMED